推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 龍蟒佰利聯(lián)發(fā)布2020年三季報(bào)，前三季度實(shí)現(xiàn)營收98.98億元，同比增加19.67%，歸母凈利潤(rùn)為19.50億元，同比減少5.62%。第三季度，公司營收為35.73億元，同比增長(zhǎng)22.79%，歸母凈利潤(rùn)為6.57億元，同比減少17.52%。
報(bào)告期末，公司在建工程達(dá)22.04億元，較期初增加33.25%，主要為50萬噸攀西鈦精礦升級(jí)轉(zhuǎn)化氯化程等改擴(kuò)建工程投入增加所致。該項(xiàng)目將國產(chǎn)鈦精礦升級(jí)為氯化鈦渣，用于氯化法生產(chǎn)金紅石型鈦白粉。項(xiàng)目投產(chǎn)后可進(jìn)一步降低原料成本，保障氯化法長(zhǎng)期穩(wěn)定的原料來源。據(jù)公司公告，該項(xiàng)目建成后預(yù)計(jì)實(shí)現(xiàn)年收入16.36億元，年均凈利潤(rùn)1.38億元。
此外，公司海綿鈦項(xiàng)目持續(xù)推進(jìn)，根據(jù)10月16日公告，祿豐新立擬將海綿鈦相關(guān)資產(chǎn)評(píng)估作價(jià)6.04億元注入其全資子公司祿豐國鈦，有利于提高運(yùn)營效率，優(yōu)化資源配置，進(jìn)一步推動(dòng)“鈦精礦—氯化鈦渣—氯化法鈦白粉—海綿鈦—鈦合金全“產(chǎn)業(yè)鏈的優(yōu)化升級(jí)。
